LEADER 01683nam  2200421 a 450 
001 9910701841503321
005 20120612145351.0
035   $a(CKB)5470000002421694
035   $a(OCoLC)795241779
035   $a(EXLCZ)995470000002421694
100   $a20120612d1977      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBioassay of dapsone for possible carcinogenicity$b[electronic resource] /$fCarcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health ; prepared at Tracor Jitco
210  1$aBethesda, Md. :$cDept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health,$d1977.
215   $a1 online resource (xi, 97 pages) $cillustrations
225 1 $aDHEW publication ; no. (NIH) 77-820
225 1 $aCarcinogenesis technical report series ;$vno. 20
300   $aTitle from title screen (viewed on June 12, 2012).
300   $a"NCI-CG-TR-20."
300   $a"CAS No. 80-08-0."
320   $aIncludes bibliographical references (pages 43-44).
606   $aLeprosy
606   $aCarcinogenesis
606   $aCarcinogens
615  0$aLeprosy.
615  0$aCarcinogenesis.
615  0$aCarcinogens.
712 02$aCarcinogenesis Program (National Cancer Institute (U.S.)).$bCarcinogen Bioassay and Program Resources Branch.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701841503321
996   $aBioassay of dapsone for possible carcinogenicity$93130818
997   $aUNINA